MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-17-0002644
Market Cap
₹48.04 Cr
AMKAY · BSE
Share Price
₹53.50
-3.60% today
Revenue
₹42.03 Cr
FY 2025-26 · +9.5% YoY
EBITDA
₹3.86 Cr
Margin 9.2%
Net Profit
₹2.06 Cr
FY 2025-26 · +1.5% YoY
P/E (TTM)
23.5x
P/B 1.8x
ROE
9.2%
ROCE 12.7%
Debt / Equity
0.13
Interest cover 14.4x
About Amkay Products Limited
Data last updated:
Amkay Products Limited is a public limited company based in Vasai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 25 October 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L51397MH2007PLC175403. Its GSTIN is 27AAGCA6560N1Z8 (Maharashtra). The company holds 3 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 544169.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹8.66 Cr. It is led by directors including Kashyap Pravin Mody (Managing Director) and Hemanshu Kantilal Batavia (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Bunglow No.68 Rashmi Park Chs Ltd Dhumal Nagar Waliv Road Tal – Vasai Dist – Thane, Maharashtra, India – 401208.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹42.03 Cr, a growth of 9.5% compared to the previous year. For the same year it recorded a net profit of ₹2.06 Cr (net margin 4.9%) and EBITDA of ₹3.86 Cr (EBITDA margin 9.2%). The net worth stands at ₹26.38 Cr (up 9.6% YoY). Total assets are valued at ₹30.48 Cr (up 13.8% YoY).
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Amkay Products. As per MCA filings, the company has open charges of ₹15.51 Cr and satisfied charges of ₹16.79 Cr on record. The company has 11 deals on record (10 market trades, 1 ipo); the latest was in December 2025. Its 3 peer companies in the Healthcare industry (Medical Consumables, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Zenith Enzymatic Drugs Private Limited with revenue of ₹39.93 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 60 overdue payments to 5 micro and small suppliers.
Amkay Products Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0002644). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amkayproducts.com.
Company details
CIN L51397MH2007PLC175403
Registration Number 175403
Incorporation Date 25 October 2007
ROC Mumbai
Listing Status Listed - Listed on BSE (544169)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0002644
CIN history
Amkay Products has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L51397MH2007PLC175403, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51397MH2007PLC175403 | Current |
| U51397MH2007PLC175403 | Previous |
| U51397MH2007PTC175403 | Previous |
Key People
Kashyap Pravin Mody Managing Director Hemanshu Kantilal Batavia Whole-Time Director Anamika Ajmera Director Recognitions & Rankings of Amkay Products
Contact details
Amkay Products Limited's registered office is in Vasai, Maharashtra.
- Social Media
- Registered AddressBunglow No.68 Rashmi Park Chs Ltd Dhumal Nagar Waliv Road Tal – Vasai Dist – Thane, Maharashtra, India – 401208
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Amkay Products Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Amkay Products operates one associated brand: Amkay Products. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medical disposables and home healthcare products are manufactured and distributed. | amkayproducts.com |
Business activity
The main business activity of Amkay Products is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amkay Products Limited, buy the company report.
Financials of Amkay Products Limited
FY 2025-26 filings availableAmkay Products Limited reported revenue of ₹42.03 Cr (up 9.5% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹42.03 Cr
+9.5% YoY
EBITDA
₹3.86 Cr
-6.5% YoY
Profit After Tax
₹2.06 Cr
+1.5% YoY
Net Worth
₹26.38 Cr
+9.6% YoY
Total Assets
₹30.48 Cr
+13.8% YoY
Total Debt
₹3.92 Cr
+48.5% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 42.03 | 38.39 | 31.07 | 27.86 | 36.50 | 40.63 | 26.41 |
| Revenue growth | +9.5% | +23.6% | +11.5% | -23.7% | -10.2% | +53.8% | - |
| EBITDA | 3.86 | 4.13 | 3.32 | 2.92 | 2.68 | 4.49 | 1.59 |
| EBITDA margin | +9.2% | +10.8% | +10.7% | +10.5% | +7.3% | +11.1% | +6.0% |
| Profit before tax | 3.22 | 4.30 | 3.49 | 2.22 | 2.02 | 3.84 | 0.64 |
| Net profit | 2.06 | 2.03 | 1.90 | 1.29 | 1.45 | 2.88 | 0.48 |
| Net profit margin | +4.9% | +5.3% | +6.1% | +4.6% | +4.0% | +7.1% | +1.8% |
| EPS (₹) | 2.67 | 3.86 | 4.13 | 559.78 | 530.21 | 1,028.57 | 171.43 |
| Balance sheet | |||||||
| Total assets | 30.48 | 26.79 | 15.53 | 12.12 | 10.59 | 6.37 | 4.32 |
| Net worth | 26.38 | 24.07 | 10.00 | 7.38 | 6.21 | 5.95 | 2.70 |
| Total debt | 3.92 | 2.64 | 5.47 | 4.70 | 4.33 | 0.42 | 1.62 |
| Cash & bank | 3.18 | 1.54 | 0.11 | 0.05 | 0.20 | 0.03 | 0.17 |
| Net working capital | 17.69 | 14.06 | 9.08 | 5.53 | 3.16 | (0.93) | 0.95 |
| Cash flow | |||||||
| Cash from operations | 1.18 | (0.31) | (0.66) | 0.01 | (0.25) | 0.00 | 0.00 |
| Cash from investing | (0.40) | (5.84) | 0.48 | (0.34) | (3.07) | 0.00 | 0.00 |
| Cash from financing | 0.86 | 7.58 | 0.24 | 0.31 | 2.59 | 0.00 | 0.00 |
| Particulars | Mar 2024 | Dec 2023 |
|---|---|---|
| Revenue | 8.32 | 8.37 |
| Other income | 0.14 | 0.62 |
| Total expenses | 7.54 | 7.61 |
| EBITDA | 0.78 | 0.76 |
| EBITDA margin | +9.4% | +9.1% |
| Depreciation | 0.05 | 0.25 |
| Interest | 0.13 | 0.15 |
| Profit before tax | 0.74 | 0.98 |
| Tax | 0.27 | 0.14 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
| Particulars | Mar 2024 | Dec 2023 |
|---|---|---|
| Revenue | 8.32 | 8.37 |
| Other income | 0.14 | 0.62 |
| Total expenses | 7.54 | 7.61 |
| EBITDA | 0.78 | 0.76 |
| EBITDA margin | +9.4% | +9.1% |
| Depreciation | 0.05 | 0.25 |
| Interest | 0.13 | 0.15 |
| Profit before tax | 0.74 | 0.98 |
| Tax | 0.27 | 0.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 42.03 | 38.39 | 31.07 | 27.86 | 36.50 | 40.63 | 26.41 |
| Revenue growth | +9.5% | +23.6% | +11.5% | -23.7% | -10.2% | +53.8% | - |
| Other income | 0.67 | 1.32 | 1.25 | 0.46 | 0.29 | 0.10 | 0.04 |
| Total expenses | 38.17 | 34.26 | 27.75 | 24.94 | 33.82 | 36.14 | 24.82 |
| Employee cost | 3.68 | 2.97 | 2.41 | 1.98 | 2.34 | 2.63 | 2.03 |
| EBITDA | 3.86 | 4.13 | 3.32 | 2.92 | 2.68 | 4.49 | 1.59 |
| EBITDA margin | +9.2% | +10.8% | +10.7% | +10.5% | +7.3% | +11.1% | +6.0% |
| Depreciation | 0.88 | 0.83 | 0.56 | 0.69 | 0.54 | 0.51 | 0.52 |
| Interest | 0.43 | 0.32 | 0.52 | 0.47 | 0.41 | 0.24 | 0.47 |
| Profit before tax | 3.22 | 4.30 | 3.49 | 2.22 | 2.02 | 3.84 | 0.64 |
| Tax | 0.89 | 0.96 | 0.87 | 0.68 | 0.57 | 0.96 | 0.16 |
| Net profit | 2.06 | 2.03 | 1.90 | 1.29 | 1.45 | 2.88 | 0.48 |
| Net profit margin | +4.9% | +5.3% | +6.1% | +4.6% | +4.0% | +7.1% | +1.8% |
| EPS (₹) | 2.67 | 3.86 | 4.13 | 559.78 | 530.21 | 1,028.57 | 171.43 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 8.66 | 8.66 | 6.36 | 0.28 | 0.28 | 0.28 | 0.28 |
| Reserves & surplus | 17.72 | 15.41 | 3.64 | 7.10 | 5.93 | 5.67 | 2.42 |
| Shareholders' funds (net worth) | 26.38 | 24.07 | 10.00 | 7.38 | 6.21 | 5.95 | 2.70 |
| Secured loans | 0.99 | 1.51 | 1.24 | 1.14 | 0.02 | (0.88) | 0.45 |
| Unsecured loans | 2.93 | 1.13 | 4.23 | 3.56 | 4.31 | 1.30 | 1.17 |
| Total debt | 3.92 | 2.64 | 5.47 | 4.70 | 4.33 | 0.42 | 1.62 |
| Total liabilities | 30.48 | 26.79 | 15.53 | 12.12 | 10.59 | 6.37 | 4.32 |
| Assets | |||||||
| Gross block | 12.24 | 11.22 | 8.90 | 8.17 | 8.16 | 6.72 | 5.56 |
| Net block | 4.27 | 4.13 | 2.58 | 2.41 | 3.91 | 2.55 | 1.90 |
| Capital work in progress | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 6.50 | 6.85 | 2.57 | 3.62 | 2.79 | 0.40 | 0.00 |
| Inventories | 9.64 | 8.12 | 5.61 | 2.61 | 1.98 | 0.29 | 0.21 |
| Sundry debtors | 4.93 | 6.01 | 3.99 | 3.70 | 3.63 | 4.50 | 2.26 |
| Cash & bank balances | 3.18 | 1.54 | 0.11 | 0.05 | 0.20 | 0.03 | 0.17 |
| Loans & advances | 2.77 | 1.49 | 1.78 | 2.03 | 2.57 | 1.94 | 0.86 |
| Total current assets | 20.52 | 17.16 | 11.49 | 8.39 | 8.38 | 6.76 | 3.50 |
| Total current liabilities | 2.83 | 3.10 | 2.41 | 2.86 | 5.22 | 7.69 | 2.55 |
| Net working capital | 17.69 | 14.06 | 9.08 | 5.53 | 3.16 | (0.93) | 0.95 |
| Total assets | 30.48 | 26.79 | 15.53 | 12.12 | 10.59 | 6.37 | 4.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 1.54 | 0.11 | 0.05 | 0.06 | 0.92 | 0.00 | 0.00 |
| Net cash from operating activities | 1.18 | (0.31) | (0.66) | 0.01 | (0.25) | 0.00 | 0.00 |
| Net cash from investing activities | (0.40) | (5.84) | 0.48 | (0.34) | (3.07) | 0.00 | 0.00 |
| Net cash from financing activities | 0.86 | 7.58 | 0.24 | 0.31 | 2.59 | 0.00 | 0.00 |
| Net change in cash | 1.64 | 1.43 | 0.06 | (0.01) | (0.72) | 0.00 | 0.00 |
| Closing cash | 3.18 | 1.54 | 0.11 | 0.05 | 0.20 | 0.03 | 0.17 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +9.5% | +23.6% | +11.5% | -23.7% | -10.2% | +53.8% | - |
| EBITDA growth | -6.5% | +24.4% | +13.7% | +9.0% | -40.3% | +182.4% | - |
| PBT growth | -25.1% | +23.2% | +57.2% | +9.9% | -47.4% | +500.0% | +9997.0% |
| Net income growth | +1.5% | +6.8% | +47.3% | -11.0% | -49.7% | +500.0% | - |
| Revenue CAGR (3Y) | +14.7% | +1.7% | -8.6% | +1.8% | - | - | - |
| EBITDA CAGR (3Y) | +9.8% | +15.5% | -9.6% | +22.5% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +5.5% | +8.7% | +8.4% | +5.5% | +4.0% | +7.1% | +1.8% |
| Return on capital employed | +12.7% | +16.8% | +22.3% | +20.8% | +28.9% | +76.3% | +25.7% |
| Return on net worth | +9.2% | +11.9% | +22.0% | +19.1% | +24.2% | +66.6% | +17.8% |
| Debt / equity | 0.13 | 0.24 | 0.58 | 0.67 | 0.39 | 0.24 | 0.60 |
| Long-term debt / equity | 0.03 | 0.07 | 0.24 | 0.41 | 0.33 | 0.30 | 0.47 |
| Interest cover | 14.43 | 9.70 | 18.84 | 21.08 | 19.16 | 6.03 | 43.93 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.58 | 3.82 | 3.64 | 3.41 | 4.91 | 6.63 | 4.75 |
| Inventory turnover | 4.73 | 5.59 | 7.56 | 12.14 | 32.16 | 162.80 | 125.86 |
| Debtors turnover | 7.68 | 7.68 | 8.08 | 7.60 | 8.98 | 12.04 | 11.69 |
| EPS (₹) | 2.67 | 3.86 | 4.13 | 559.78 | 530.21 | 1,028.57 | 171.43 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 30.47 | 27.80 | 15.72 | 2,664.15 | 2,242.86 | 2,125.00 | 964.29 |
To see the full year-wise statements and ratios of Amkay Products Limited, buy the company report.
Board of directors of Amkay Products Limited
Amkay Products has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kashyap Pravin Mody | Managing Director | 25 Oct 2007 | 18 Years 11 Months | Current |
| Hemanshu Kantilal Batavia | Whole-Time Director | 12 Jan 2011 | 15 Years 9 Months | Current |
| Anamika Ajmera Also directs: Macfos Limited, Meta Infotech Limited, Wizworth International Private Limited and 2 more | Director | 28 Aug 2023 | 3 Years 1 Months | Current |
| Gaurav Maheshwari Also directs: Readymix Construction Machinery Limited, Srfi Pulses Limited | Director | 28 Aug 2023 | 3 Years 1 Months | Current |
| Ajay Somabhai Mehta | Director | 26 Jun 2023 | 3 Years 3 Months | Current |
Peer comparison
Amkay Products Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical Consumables, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amkay Products Limitedthis company | ₹42.03 Cr (FY 2026) | ₹2.06 Cr | 4.9% | 9.5% | Vasai, Maharashtra, India | |
| Zenith Enzymatic Drugs Private Limited | ₹39.93 Cr (FY 2024) | 6.0% | Pune, Maharashtra, India | |||
| SPM Medicare Private Limited | ₹39.92 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Shruti Drugs Private Limited | ₹39.47 Cr (FY 2025) | 35.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Amkay Products Limited, buy the company report.
Charges & borrowings
Open charges
₹15.51 Cr
Satisfied charges
₹16.79 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2026 | 101264416 | Axis Bank Limited | ₹12.94 Cr | Open | |
| 11 Jan 2024 | 100846759 | Sidbi | ₹1 Cr | Open | |
| 09 Feb 2023 | 100677152 | Sidbi | ₹92 Lakh | Open | |
| 01 Aug 2022 | 100598720 | Sidbi | ₹65 Lakh | Open | |
| 08 Apr 2025 | 101095978 | Others | ₹75 Lakh | Satisfied |
To see the full charge records of Amkay Products Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Amkay Products Limited has 11 deals on record (10 market trades, 1 ipo); the latest was in December 2025.
Total deals
11
Market trades
10
IPO
1
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2025 | Market trade | ₹79.2 Lakh | Buyer: an individual |
| May 2024 | Market trade | ₹1.63 Cr | Buyer: Topgain Finance Private Limited , Camellia Tradex Private Limited Seller: Mountain Ventures |
| May 2024 | Market trade | ₹7.9 Cr | Buyer: Mountain Ventures, Spring Ventures, Green Peaks Enterprises LLP , an individual Seller: Cinco Stock Vision LLP , Yuga Stocks & Commodities Private Limited , Green Peaks Enterprises LLP , an individual |
| May 2024 | Market trade | ₹1.34 Cr | Buyer: Cinco Stock Vision LLP |
| May 2024 | Market trade | ₹6.09 Cr | Buyer: Yuga Stocks & Commodities Private Limited , Green Peaks Enterprises LLP , Stock Vertex Ventures, an individual |
To see the full deal history of Amkay Products Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Amkay Products Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Amkay Products Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 60 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Care Pack Industries | |||
| Thea-Tex Healthcare (India) Private Limited | |||
| VSN Plas - Pack | |||
| an individual supplier |
To see the full MSME payment records of Amkay Products Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Amkay Products has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCA6560N1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amkay Products Limited, buy the company report.
Recent activity
Amkay Products Limited has 10 board changes on record since 2007: 5 appointments and 5 cessations. The latest: Ajay Somabhai Mehta ceased to be Additional Director on 29 Aug 2023.
Charges
A charge with Axis Bank Limited of Rs. 12.94 Cr registered on 21 Feb 2026 with Charge ID 101264416 was modified on 11 Aug 2026.
Charges
A charge registered on 08 Apr 2025 via Charge ID 101095978 with Others was fully satisfied on 09 Jul 2026.
Charges
A charge registered on 08 Apr 2025 via Charge ID 101095986 with Others was fully satisfied on 09 Jul 2026.
Filing
Amkay Products Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge with Axis Bank Limited amounted to Rs. 12.94 Cr with Charge ID 101264416 was registered on 21 Feb 2026.
AGM
Amkay Products Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 0.75 Cr registered on 08 Apr 2025 with Charge ID 101095978 was modified on 08 Aug 2025.
Charges
A charge with Others of Rs. 10.25 Cr registered on 08 Apr 2025 with Charge ID 101095986 was modified on 08 Aug 2025.
Charges
A charge registered on 02 Feb 2015 via Charge ID 10551043 with Axis Bank Limited was fully satisfied on 28 Jul 2025.
Charges
A charge with Others amounted to Rs. 0.75 Cr with Charge ID 101095978 was registered on 08 Apr 2025.
Charges
A charge with Others amounted to Rs. 10.25 Cr with Charge ID 101095986 was registered on 08 Apr 2025.
Charges
A charge with Axis Bank Limited of Rs. 4.51 Cr registered on 02 Feb 2015 with Charge ID 10551043 was modified on 11 Sep 2024.
22 earlier events are in the company report.
Frequently asked questions
Amkay Products is an active public limited company based in Vasai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 25 October 2007 (19+ years old) and is registered under CIN L51397MH2007PLC175403. Listed on BSE: 544169.
Amkay Products reported revenue of ₹42.03 Cr for FY 2025-26 (up 9.5% YoY) based on standalone financials.
Amkay Products has 5 current directors:
- Kashyap Pravin Mody - Managing Director
- Hemanshu Kantilal Batavia - Whole-Time Director
- Anamika Ajmera - Director
- Gaurav Maheshwari - Director
- Ajay Somabhai Mehta - Director
The latest financial statements of Amkay Products on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Amkay Products is 27AAGCA6560N1Z8, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Amkay Products is L51397MH2007PLC175403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Amkay Products is a listed company as per MCA records. Its shares are listed on BSE (code: 544169).
Amkay Products was incorporated on 25 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Amkay Products has 11 deals on record (10 market trades, 1 ipo); the latest was in December 2025.
The peers of Amkay Products by revenue are Zenith Enzymatic Drugs Private Limited, SPM Medicare Private Limited, Shruti Drugs Private Limited, all in the Healthcare industry (Medical Consumables, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajay Somabhai Mehta ceased to be Additional Director on 29 Aug 2023. Anamika Ajmera ceased to be Additional Director on 29 Aug 2023. Gaurav Maheshwari ceased to be Additional Director on 29 Aug 2023. Amkay Products has 10 board changes on record in total.
Yes, Amkay Products is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0002644).